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ABSTRACT Prolonged exposure ofcells or tissues to drugs
or hormones such as catecholamines leads to a state of
refractoriness to further stimulation by that agent, known as
homologous desensitization. In the case of the fi-adrenergic
receptor coupled to adenylate cyclase, this process has been
shown to be intimately associated with the sequestration of the
receptors from the cell surface through a cAMP-independent
process. Recently, we have shown that homologous desensiti-
zation in the frog erythrocyte model system is also associated
with increased phosphorylation of the f3-adrenergic receptor.
We now provide evidence that the phosphorylation state of the
13-adrenergic receptor regulates its functional coupling to
adenylate cyclase, subcellular translocation, and recycling to
the cell surface during the process of agonist-induced homol-
ogous desensitization. Moreover, we show that the receptor
phosphorylation is reversed by a phosphatase specifically
associated with the sequestered subcellular compartment. At
230C, the time courses of (3-adrenergic receptor phosphoryl-
ation, sequestration, and adenylate cyclase desensitization are
identical, occurring without a lag, exhibiting a til2 of 30 min,
and reaching a maximum at w3 hr. Upon cell lysis, the
sequestered ,B-adrenergic receptors can be partially recovered
in a light membrane vesicle fraction that is separable from the
plasma membranes by differential centrifugation. The in-
creased ,B-adrenergic receptor phosphorylation is apparently
reversed in the sequestered vesicle fraction as the sequestered
receptors exhibit a phosphate/receptor stoichiometry that is
similar to that observed under basal conditions. High levels of
a /3-adrenergic receptor phosphatase activity appear to be
associated with the sequestered vesicle membranes. The func-
tional activity of the phosphorylated ,B-adrenergic receptor was
examined by reconstituting purified receptor with its biochem-
ical effector the guanine nucleotide regulatory protein (Nj) in
phospholipid vesicles and assessing the receptor-stimulated
GTPase activity of N8. Compared to controls, phosphorylated
(3-adrenergic receptors, purified from desensitized cells, were
less efficacious in activating the N8 GTPase activity. These
results suggest that phosphorylation of the ,B-adrenergic re-
ceptor leads to its functional uncoupling and physical translo-
cation away from the cell surface into a sequestered membrane
domain. In the sequestered compartment, the phosphorylation
is reversed thus enabling the receptor to recycle back to the cell
surface and recouple with adenylate cyclase.
Prolonged exposure of target cells to hormone agonists
results in diminished cellular responsiveness to further hor-
monal stimulation through a process known as desensitiza-
tion. Hormone-induced desensitization has been extensively
investigated in a variety of cells that contain ,B-adrenergic
receptors coupled to the stimulation of adenylate cyclase
activity. Desensitization of P-adrenergic receptor-coupled
adenylate cyclase is generally divided into two major cate-
gories. One form is referred to as homologous and is
distinguished by the fact that only stimulation by ,-adrener-
gic agonists is attenuated (1-3). Conversely, heterologous
desensitization is characterized by a diminished responsive-
ness to additional hormones and to nonhormonal activators
such as guanine nucleotides and fluoride ion (1-3).
Recent information has indicated that heterologous desen-
sitization is associated with phosphorylation and functional
uncoupling of the p-adienergic receptor, which is mediated,
at least in part, by the cAMP-dependent protein kinase (4-7).
In contrast, homologous desensitization appears to involve
the sequestration or removal of the f3adrenergic receptors
away from the cell surface through a cAMP-independent
process (1-3). The location of the sequestered ,B-adrenergic
receptors in desensitized cells is not yet known with certain-
ty. Evidence has accumulated that the sequestered ,3adren-
ergic receptors can be recovered in small vesicular membrane
particles, which, under basal conditions, are nearly devoid of
receptors (1-3). It is not yet clear whether these light
membrane particles actually represent endocytotic vesicles
or whether they might be a sequestered domain of the plasma
membrane (8, 9). Whether or not the P3-adrenergic receptors
become functionally modified or uncoupled during homolo-
gous desensitization in addition to their physical sequestra-
tion is also currently a point of controversy (10-15). Recent-
ly, we have demonstrated that homologous desensitization is
associated with increased phosphorylation of the f-adrener-
gic receptor (16, 17). This phosphorylation process is phar-
macologically specific, stoichiometric, and may be mediated
by a f3-adrenergic receptor kinase (16-18). In the present
investigation, we demonstrate a direct correlation between
the phosphorylation state of the /3-adrenergic receptor and
both its functionality and subcellular location. Our results
further suggest that dephosphorylation and reactivation of
the receptor are functions specifically accomplished in the
sequestered compartment of the cell.
MATERIALS AND METHODS
Materials. [y-32P]GTP and 32P, (carrier free) were obtained
from New England Nuclear. 3H-labeled 4-{3-[1,1-dimethyl-
(ethyl)amino]-2-hydroxypropoxy}-1,3-dihydro-2H-benzim-
idazol-2-one ([3H]CGP12177) (30-50 Ci/mmol; 1 Ci = 37
GBq) was from Amersham. Soybean phosphatidylcholine,
bovine serum albumin (fraction V), polyethylene glycol, and
Abbreviations: [3H]CGP12177, 3H-labeled 4-{3-[1,1-dimethyl(ethyl)-
amino]-2-hydroxypropoxy}-1,3-dihydro-2H-benzimidazol-2-one;
N, stimulatory nucleotide regulatory protein.
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p-nitrophenyl phosphate were from Sigma. Extracti-Gel D
was from Pierce. Octyl f3-D-glucopyranoside (octyl gluco-
side) was from Calbiochem-Behring. All other materials were
from sources described (5).
32p Incorporation into Frog Erythrocyte .8-Adrenergic Re-
ceptors. Washed frog erythrocytes were suspended to 20%
hematocrit in 110 mM NaCl/10 mM glucose/20 mM sucrose/
17mM Tris HCl, pH 7.4 (buffer A), with 300 units of penicillin
per ml and 1 mg of streptomycin per ml. The cells were
incubated with carrier-free 32P, (0.5 mCi/ml) at 230C for 20 hr
to allow 32p incorporation into the intracellular ATP. After
the 32p incorporation, 0.2 mM sodium metabisulfite was
added to each flask of cells, which were then further
incubated in the absence (control) or presence (desensitized)
of 10 gM (-)-isoproterenol for 3 hr or as indicated. The cells
were then washed three times with buffer A and lysed either
by hypotonic shock in 5 mM MgCl2/5 mM Tris HCl, pH 7.4,
or by Dounce homogenization in ice-cold H20 as described
below.
Membrane Preparations and Receptor Purification. The
location of the sequestered 0-adrenergic receptors in desen-
sitized cells is not known with certainty. The observation that
upon cell lysis the sequestered receptors appear to be
translocated into light membrane particles has suggested that
they reside in cytoplasmic vesicles (1-3). However, we have
recently demonstrated that in frog erythrocytes the produc-
tion of these vesicular particles is dependent on the method
of cell lysis (8, 16, 19). If the desensitized cells are lysed in
H20 using a Potter-Elvehjem homogenizer, then a portion of
the sequestered receptors can be recovered in a light mem-
brane fraction obtained by high-speed centrifugation of the
cell cytosol (8, 19). In contrast, if the cells are lysed by
freezing and thawing or by hypotonic shock in the absence of
homogenization, then the sequestered receptors can be found
associated with the plasma membrane fraction (8, 16).
In the present investigation, we have used two different
membrane preparations. One involves hypotonic lysis of the
cells in 5 mM MgCl2/5 mM Tris-HCl, pH 7.4, without
homogenization followed by centrifugation at 30,000 x g for
10 min. This results in a membrane pellet containing the total
cellular pool of P-adrenergic receptors-that is, the cell-
surface receptors in addition to the receptors sequestered
from the cell surface. In the second method, the cells are
lysed by Dounce homogenization in ice-cold H20 followed by
centrifugation at 30,000 x g for 10 min. The low-speed pellet
contains plasma membranes that are contaminated with some
sequestered vesicle membranes (ref. 8; unpublished obser-
vations). The supernatant fraction is further centrifuged at
158,000 x g for 1 hr. The resulting high-speed pellet consists
solely of the sequestered vesicular membrane receptors (8,
19). The Dounce homogenization was less efficient than that
of the Potter-Elvehjem for separating the sequestered vesicle
particles from the plasma membranes but was necessary
when using 32P-labeled cells because of the high levels of
radioactivity.
The subsequent solubilization, affinity chromatography,
and concentration of the 0-adrenergic receptors were per-
formed exactly as described (5, 16). After desalting on
Sephadex G-50 columns, each sample was assayed for
maximal receptor binding with [1251I]iodocyanopindolol fol-
lowed by lyophilization and resuspension in NaDodSO4/
PAGE sample buffer. NaDodSO4/PAGE and autoradi-
ography were performed as described (5, 16).
Preparation of the Stimulatory Nucleotide Regulatory Pro-
tein (Nj). N, was purified by a procedure similar to that of
Sternweis (20). Briefly, bovine brain membranes were pre-
pared and solubilized with sodium cholate. Solubilized N.
was then successively chromatographed on DEAE-Sepha-
cel, Ultrogel AcA-34, octyl-Sepharose, and hydroxylapatite,
followed by a final purification step on DEAE-Sephacel.
Insertion of fi-Adrenergic Receptors and N, into Phospho-
lipid Vesicles. ,3Adrenergic receptors from control or desen-
sitized erythrocytes were purified by affinity chromatogra-
phy and inserted into phospholipid vesicles with purified Ns
as described (13, 21). /3-Adrenergic receptor (5-10 pmol in
<150 1d) and Ns (15 pmol in <15 ILI) were incubated with
bovine serum albumin (2 mg/ml)/1.5 mM sonicated soybean
phosphatidylcholine/0.85% (wt/vol) octyl glucoside on ice
for 30 min. The detergent concentration was then reduced by
chromatography on 1 ml of Extracti-Gel D columns, which
were eluted with 100 mM NaCl/20 mM MgCl2/10 mM
Tris'HCl, pH 7.4. The eluates (2 ml) were added to 0.6 ml of
polyethylene glycol 8000 [final concentration, 12.5% (wt/
vol)] and incubated for 10 min at 220C followed by dilution
and centrifugation at 250,000 x g for 90 min at 4°C. The
protein-lipid pellets were suspended in 100 mM NaCl/10 mM
Tris HCl, pH 7.4, and assayed for radioligand binding with
[125I]iodocyanopindolol or GTP hydrolytic activity.
GTP Hydrolytic Activity (GTPase). The GTPase activity
was assayed by incubating 20 ,ul of the phospholipid vesicles
containing f3-adrenergic receptors and Ns in a total vol of 100
,ul containing 10 mM Tris HCl (pH 7.8), 10 mM MgCl2, 1 mM
EDTA, 0.2% bovine serum albumin, 1 mM adenyl-5'-yl-
imidodiphosphate, and 100-200 nM [y-32P]GTP (-40,000
cpm/pmol). The assay was stopped by the addition of 10 ul
of cold 50% trichloroacetic acid and centrifugation at 1000 X
g for 20 min. The supernatant was assayed for inorganic 32Pi
as described (21).
Radioligand Binding and Adenylate Cyclase Assays. Soluble
03-adrenergic receptor binding assays were performed as
described (5) using a saturating (300 pM) concentration of
[1251]iodocyanopindolol. Intact cell [3H]CGP12177 binding
assays were performed as described (17) using 2.5 X 107
erythrocytes and 10 nM [3H]CGP12177. Adenylate cyclase
assays were performed as described (5) using frog erythro-
cyte membranes prepared by hypotonic lysis of the cells.
Protein was assayed by the method of Lowry et al. (22).
RESULTS
Recent data (23) have suggested that in astrocytoma cells,
agonist-induced desensitization can be temporally dissoci-
ated from receptor sequestration with the former event
preceding the latter. We thus wished to initially compare the
rates of ,B-adrenergic receptor phosphorylation, receptor
sequestration, and adenylate cyclase desensitization in frog
erythrocytes. Fig. 1 shows that isoproterenol-induced recep-
tor phosphorylation occurs without a lag, achieving a max-
imal level at 2.5-3 hr with a til2 of =30 min. Similarly, the
agonist-induced loss of isoproterenol-stimulated adenylate
cyclase activity and loss of cell-surface receptor binding
(monitored with the membrane-impermeable ,B-adrenergic
antagonist [3H]CGP12177) both proceed without a lag and
reached maximal levels at -3 hr. The rates of,-adrenergic
receptor phosphorylation, sequestration, and desensitization
are thus identical in frog erythrocytes. This is consistent with
the notion that receptor phosphorylation is intimately asso-
ciated with the processes of homologous desensitization and
sequestration of the P-adrenergic receptor.
It should be noted (Fig. 1) that the maximum extent of
receptor sequestration (=35%) is not as great as the extent of
desensitization (==50%). This might suggest that sequestra-
tion of receptors from the cell surface may not fully explain
the desensitization and that phosphorylation may addition-
ally produce a functional alteration or uncoupling of the
receptors. To test this hypothesis, we purified the total
cellular pool of 8-adrenergic receptors from control and
desensitized cells and directly tested their ability to couple
with N, in phospholipid vesicles. The purified N. protein has
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FIG. 1. Time course of isoproterenol-induced 3-adrenergic re-
ceptor phosphorylation, receptor sequestration, and adenylate cy-
clase desensitization. Frog erythrocytes were 32P-labeled and then
incubated in the absence (control) or presence of 10 ,uM
isoproterenol for the indicated times at 23°C. The cells were then
lysed hypotonically in 5 mM MgCl2/5 mM Tris HCl, pH 7.4, and
membranes were prepared as described. The 3-adrenergic receptors
were purified and assessed for 32p incorporation on NaDodSO4/
PAGE. The phosphorylation data (o) are expressed as percentage of
maximum increase in the phosphate/receptor stoichiometry
(mol/mol) over the basal level (0.57 mol/mol). Adenylate cyclase
activities (o) were determined and expressed as a percentage of the
control value, which was 98 pmol-min'lmg-1. Unlabeled frog
erythrocytes were incubated with 10 ,uM isoproterenol in parallel,
washed, and assessed for [3H]CGP12177 binding (A) by using intact
cells. [3H]CGP12177 is a hydrophilic P3-adrenergic antagonist that is
membrane impermeable and restricted to binding only those recep-
tors present on the cell surface (9, 24). The control [3H]CGP12177
binding activity was 3240 receptor sites per cell. The time course
experiment shown is representative of three such experiments.
been shown to exhibit GTPase activity elicited by its inter-
action with the ,B-adrenergic receptor, which presumably
terminates hormone and GTP-induced adenylate cyclase
activation (21, 25). Fig. 2 shows the GTPase activity exhib-
ited by reconstituted control or desensitized S-adrenergic
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FIG. 2. GTPase activity of phospholipid vesicles containing N.
and 3-adrenergic receptors purified from control or desensitized
cells. Frog erythrocytes were incubated in the absence (control) or
presence of 10 AM isoproterenol (desensitized) for 3 hr at 23°C. The
cells were washed and lysed hypotonically with 5 mM MgCl2/5 mM
Tris HCl, pH 7.4, as described. The total cellular pool of /3-adren-
ergic receptors was solubilized and purified by affinity chromatog-
raphy. After purification, the 3-adrenergic receptors were inserted
into phospholipid vesicles with N, as described. Equal amounts of
control and desensitized receptor were reconstituted (1.5 pmol) as
assessed with [125I]iodocyanopindolol binding after reconstitution.
GTPase activity, as a function of the isoproterenol concentration,
was then measured at 30°C for 30 min. The basal GTPase activity was
subtracted from all isoproterenol-promoted GTPase activities. Data
represent mean ± SD (n = 3) from a single experiment, which was
performed three times with similar results.
receptors and N, as a function of isoproterenol concentra-
tion. As shown, isoproterenol markedly stimulates GTPase
activity; however, the phosphorylated receptors, purified
from desensitized cells, are impaired in their ability to couple
with N, when compared to controls. This is evident despite
the fact that equal amounts of control or desensitized 13-
adrenergic receptor are reconstituted into the phospholipid
vesicles as assessed with [1251]iodocyanopindolol binding
subsequent to the reconstitution. Phosphorylation of the
f-adrenergic receptors during homologous desensitization is
thus associated with functional alterations in the receptors in
addition to their physical sequestration.
In contrast, Strulovici et al. (10) found that the sequestered
P-adrenergic receptors from frog erythrocytes were function-
ally active in reconstituting catecholamine-sensitive adenyl-
ate cyclase in Xenopus laevis erythrocytes. Similar results
were obtained by Clark et al. (15) in characterizing the
sequestered P-adrenergic receptors in S49 lymphoma cells.
These results indicate that the sequestered receptors are in
fact functionally normal. To reconcile these previous obser-
vations with our current data using the total cellular pool of
desensitized receptors, we attempted to fractionate the
receptors from desensitized cells into plasma membrane and
sequestered membrane components and determine the phos-
phorylation states of each. For technical reasons (see Mate-
rials and Methods), however, it is not possible to prepare a
plasma membrane fraction that is devoid of sequestered
receptors. One can, however, obtain purified sequestered
membrane vesicles that are, in fact, devoid of plasma
membranes. We utilized this latter approach and the results
are shown in Fig. 3. Lane 1 of the autoradiogram shows a
purified /-adrenergic receptor preparation from control 32p_
labeled frog erythrocytes. As we previously demonstrated
(16), the frog erythrocyte P3-adrenergic receptor is phospho-
rylated under basal conditions, exhibiting a phosphate/re-
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FIG. 3. NaDodSO4/PAGE of 32P-labeled B3-adrenergic receptors
from control and desensitized frog erythrocytes. Cells were prein-
cubated with 32P, prior to incubation in the absence (control) or
presence (desensitized) of 10 gM isoproterenol for 3 hr at 230C. The
desensitized cells were then split into two groups. One group, along
with the control cells, was lysed hypotonically in 5 mM MgCl2/5 mM
Tris HCl, pH 7.4, membranes were prepared, and the receptors were
solubilized and purified. The second group of desensitized cells was
lysed by Dounce homogenization in H20 followed by preparation of
a sequestered vesicular membrane fraction as described. The recep-
tors in these membranes were subsequently purified and character-
ized on NaDodSO4/PAGE. Lanes: 1, receptor preparation from
control cells; 2, receptor preparation from the hypotonically lysed
desensitized cells consisting of the total cellular pool of receptors
(see Materials and Methods); 3, receptors purified from the seques-
tered vesicle membranes obtained from the Dounce-homogenized
desensitized cells. Equal amounts (2.6 pmol) of receptor were loaded
onto each lane ofthe gel. The experiment shown was performed three
times with similar results.
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ceptor stoichiometry (mol/mol) of 0.62 + 0.15 (n = 5). Lane
2 shows a purified receptor preparation from isoproterenol-
desensitized erythrocytes. This preparation consists of the
total pool of 3-adrenergic receptors in the desensitized cells,
including both the cell surface and the sequestered receptors.
As can be seen, the amount of phosphate incorporated into
the receptor is substantially increased. The average stoichi-
ometric value (mol of phosphate per mol of receptor) for the
total pool of receptors from desensitized cells is 2.1 ± 0.19 (n
= 7). Lane 3, however, shows a receptor preparation purified
from the sequestered vesicle membranes obtained from
desensitized cells. In this case, the level of receptor phos-
phorylation is low (0.75 ± 0.08 mol of phosphate per mol of
receptor; n = 3), similar to that observed under basal
conditions (Fig. 3, lane 1). This indicates that the major
increase in phosphorylation of the /3-adrenergic receptor
upon desensitization (lane 2) is due predominately to an
increase in the phosphorylation state of the cell-surface
receptors. Moreover, this observation suggests that the
increased receptor phosphorylation is reversed either during
or rapidly after receptor sequestration from the cell surface.
This dephosphorylation event may enable the receptor to
eventually recycle back to the cell surface.
To explore the possibility that receptor dephosphorylation
actually occurs in the sequestered vesicle compartment, we
examined the ability of various cellular fractions to promote
dephosphorylation of 32P-labeled ,3-adrenergic receptor. Fig.
4 shows that incubation of 32P-labeled receptor with an
enriched plasma membrane fraction results in partial receptor
dephosphorylation. However, incubation with a purified
sequestered vesicle fraction results in receptor dephospho-
rylation, which occurs considerably more rapidly and to a
greater extent (Fig. 4). Incubation with cell cytosol did not
result in appreciable receptor dephosphorylation (data not
shown). We further compared the ability of the plasma
membrane and vesicle membrane fractions to dephosphoryl-
ate p-nitrophenyl phosphate, a general phosphatase sub-
strate. Interestingly, the enriched plasma membrane fraction
exhibited -10-fold greater activity toward this substrate
(data not shown). Thus, even though the vesicle membranes
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FIG. 4. Dephosphorylation of 32P-labeled /3-adrenergic receptors
using plasma membranes or vesicle membranes as sources of
phosphatase activity. Frog erythrocyte membrane fractions were
prepared as described (19). Equal amounts of the plasma membrane-
enriched and the sequestered vesicle membrane fractions were
incubated with 32P-labeled receptor in 12.5 mM MgCl2/1.5 mM
EDTA/75 mM Tris HCI, pH 7.0, for the indicated times followed by
freezing, lyophilization, and characterization on NaDodSO4/PAGE.
32P-labeled receptor used as the substrate for the phosphatase assay
was prepared by phosphorylating purified hamster lung ,&adrenergic
receptor, reconstituted into phospholipid vesicles with partially
purified /3-adrenergic receptor kinase as described (18). The data
shown are representative of three such experiments.
possess =1/10th of the total phosphatase activity of the
plasma membranes, they exhibit much higher levels of
phosphatase activity when using phosphorylated /3-adre-
nergic receptor as a substrate. This suggests that the phos-
phatase responsible for reversing the increased receptor
phosphorylation likely resides in the sequestered vesicle
compartment.
DISCUSSION
The present results clearly establish a functional role for the
phosphorylation state of the P3-adrenergic receptor in homol-
ogous desensitization ofadenylate cyclase. One consequence
of receptor phosphorylation is a functional alteration in the
receptor protein that renders it less efficacious in coupling to
its effector, the guanine nucleotide binding regulatory pro-
tein, N,. The issue ofwhether or not a functional modification
occurs in the receptor during homologous desensitization has
recently been controversial. Evidence has been presented
both for (11, 12, 15, 23) and against (10, 13-15) a functional
receptor alteration. The latter investigations, however, have
primarily involved characterizing the receptors after they had
been sequestered from the cell surface. It was shown that the
sequestered receptors appeared to be functionally normal
(10, 15). Our present observations linking increased phos-
phorylation of the cell-surface receptors to functional uncou-
pling and showing that the sequestered receptors exhibit
decreased phosphorylation thus suggest a rational explana-
tion for these previously discrepant findings.
The phosphorylation state of the /3-adrenergic receptor
also appears to be intimately related to its expression on the
cell surface. Increased receptor phosphorylation in response
to agonist occupancy is shown here to directly correlate with
sequestration of the receptors from the cell surface. Once the
receptors are sequestered, the increased phosphorylation is
reversed, perhaps enabling the receptors to translocate back
to the cell surface. The steady-state subcellular distribution
of the /3-adrenergic receptors can thus be viewed as a
reflection of the opposing rates of receptor phosphorylation
and dephosphorylation. Agonist occupancy leads to an in-
crease in the rate of receptor phosphorylation and thus to a
decrease in the steady-state expression of receptors on the
cell surface. A number of other cell-surface receptors that
exhibit sequestration and recycling phenomona, such as
those for insulin, epidermal growth factor, and transferrin,
also undergo phosphorylation (26). It is thus tempting to
speculate that phosphorylation/dephosphorylation repre-
sents a general mechanism through which recycling of
receptors can be regulated.
The nature of the protein kinase and phosphatase involved
in homologous desensitization of the P3-adrenergic receptor is
not yet known with certainty. Recently, Benovic et al. (18)
have identified a 13-adrenergic receptor kinase that phospho-
rylates only the agonist-occupied form of the receptor and
that may be involved in homologous desensitization. In
contrast, very little is known concerning the receptor phos-
phatase. Our present results indicate that it is highly con-
centrated in the sequestered vesicle compartment. Although
small amounts of /3-adrenergic receptor dephosphorylating
activity were observed in the enhanced plasma membrane
fraction (Fig. 4), it is likely that this low activity is due to the
presence of contaminating membranes from the sequestered
compartment (see Materials and Methods). Preliminary ev-
idence has indicated that the action of the phosphatase on the
/3adrenergic receptor is not affected by agonist occupancy or
by the prior exposure of cells to agonists (data not shown).
This phosphatase might represent a specific 13-adrenergic
receptor phosphatase or a previously unrecognized activity
of one of the known protein phosphatases. Protein
phosphatases have generally been divided into four major
Biochemistry: Sibley et al.
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classes referred to as types 1, 2A, 21, and 2C (27). It is
interesting to note that type 1 has been shown to be
associated with liver microsomes, while type 2B has been
shown to be localized at postsynaptic densities in the brain
(27).
Our current working hypothesis for the molecular mech-
anisms involved in homologous desensitization of adenylate
cyclase is shown in Fig. 5. Agonist occupancy of the
p-adrenergic receptor leads to its phosphorylation by a
,S-adrenergic receptor kinase. This phosphorylation results in
the functional uncoupling of the receptors and triggers their
sequestration from the cell surface. In the frog erythrocyte,
these events are not temporally separable, although in some
cells (23) they appear to be. Sequestration from the cell
surface is associated with dephosphorylation of the 3-adren-
ergic receptors. The relevant phosphatase responsible for
% RECYCLING +
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\
FIG. 5. Molecular mechanisms of homologous desensitization of
f-adrenergic receptor-coupled adenylate cyclase. BAR, 3-adrener-
gic receptor; (3-ARK, P-adrenergic receptor kinase; C, catalytic unit.
dephosphorylation of the receptor likely resides in the
sequestered membrane compartment. Dephosphorylation of
the receptor restores its functionality and enables it to recycle
back to the cell surface and recouple with adenylate cyclase.
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